Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Effects on Brain Networks in pDoC
NCT06473285Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of esketamine in Prolonged Disorders of Consciousness (PDOC) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Entropy index up to 3 hours and Lempel Ziv complexity up to 3 hours. Started Jun 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Prolonged Disorders of Consciousness (PDOC)
Beyond the preview
Go deeper on NCT06473285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06473285.